gemcitabine has been researched along with 2'-deoxyadenosine triphosphate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goan, YG; Hu, E; Mi, S; Yen, Y; Zhou, B | 1 |
| Im, MM; Ljungman, M; Praz, F; Robinson, BW; Shewach, DS | 1 |
2 other study(ies) available for gemcitabine and 2'-deoxyadenosine triphosphate
| Article | Year |
|---|---|
Overexpression of ribonucleotide reductase as a mechanism of resistance to 2,2-difluorodeoxycytidine in the human KB cancer cell line.
Topics: Antimetabolites, Antineoplastic; Deoxyadenine Nucleotides; Deoxycytidine; Deoxycytosine Nucleotides; Drug Resistance, Neoplasm; Gemcitabine; Humans; KB Cells; Ribonucleotide Reductases | 1999 |
Enhanced radiosensitization with gemcitabine in mismatch repair-deficient HCT116 cells.
Topics: Base Pair Mismatch; Cell Cycle; Deoxyadenine Nucleotides; Deoxycytidine; DNA Repair; DNA, Neoplasm; Gemcitabine; HCT116 Cells; Humans; Nucleotides; Radiation Tolerance; Radiation-Sensitizing Agents | 2003 |